Showing results (71-80 of 400) with videos related to

Sort By:
Pageof 40
Journal of Cancer Research and Clinical Oncology|October 6, 2011
Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trialsFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.
Breast Cancer Research and Treatment|June 13, 2012
Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysisFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.
Anti-Cancer Drugs|January 11, 2011
Neoadjuvant chemotherapy and concomitant trastuzumab in breast cancer: a pooled analysis of two randomized trialsFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.
Nature Reviews. Urology|October 13, 2010
Progression of intramedullary metastasis during perioperative cessation of sunitinibFausto Petrelli, Mary Cabiddu, Marinella Carpo, et al.
Anti-Cancer Drugs|October 18, 2016
Modified schedules of DCF chemotherapy for advanced gastric cancer: a systematic review of efficacy and toxicityFausto Petrelli, Gianluca Tomasello, Michele Ghidini, et al.
Reviews on Recent Clinical Trials|March 9, 2010
What else in gemcitabine-pretreated advanced pancreatic cancer? An update of second line therapiesFausto Petrelli, Karen Borgonovo, Mara Ghilardi, et al.
Lung Cancer (Amsterdam, Netherlands)|July 17, 2012
Relationship between skin rash and outcome in non-small-cell lung cancer patients treated with anti-EGFR tyrosine kinase inhibitors: a literature-based meta-analysis of 24 trialsFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.
Expert Opinion on Drug Safety|August 17, 2011
Risk of anti-EGFR monoclonal antibody-related hypomagnesemia: systematic review and pooled analysis of randomized studiesFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.
Targeted Oncology|December 1, 2012
Regression of liver metastases after treatment with intraperitoneal catumaxomab for malignant ascites due to breast cancerFausto Petrelli, Karen Borgonovo, Veronica Lonati, et al.
The Oncologist|April 26, 2012
The risk for anemia with targeted therapies for solid tumorsSandro Barni, Mary Cabiddu, Paolo Guarneri, et al.
Pageof 40